Changchun Bcht Biotechnology Co. Class ASSE: 688276

Announcement on the Approval of Voluntary Disclosure of Clinical Trial Application for Freeze-dried Haemophilus Influenzae Type b Conjugate Vaccine

· Issued by Changchun Bcht Biotechnology Co. Class A via Shanghai Stock Exchange
Announcement on the Approval of Voluntary Disclosure of Clinical Trial Application for Freeze-dried Haemophilus Influenzae Type b Conjugate Vaccine

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis